ACM BIOLABS
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
ACM Biolabs Announces Positive Topline Results from a Phase I Trial of SARS-CoV-2 Booster Vaccine ACM-001 2023-09-05 14:00
ACM Biolabs Announces Positive Topline Results from a Phase I Trial of SARS-CoV-2 Booster Vaccine ACM-001 2023-09-05 14:00
ACM Biolabs Further Strengthens Leadership, Appoints David Lawrence to Board of Directors 2023-04-11 19:00
As part of 'Operation Nasal Vaccine' to counter COVID-19 spread, ACM-001 booster vaccine administered to first subject in phase 1 safety and immunogenicity trial 2022-07-29 16:00
Second Positive PED Animal Trials Completed Using ACM Biolabs' Technology 2016-10-04 22:00
1